Tabelecleucel
ATA129-NPC-202
Phase 2 mab terminated
Quick answer
Tabelecleucel for Nasopharyngeal Carcinoma is a Phase 2 program (mab) at Atara Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atara Biotherapeutics
- Indication
- Nasopharyngeal Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated